Superdiluted atropine at 0.01% reduces progression in children and adolescents. A 5 year study of safety and effectiveness.

Superdiluted atropine at 0.01% reduces progression in children and adolescents. A 5 year study of safety and effectiveness. Arch Soc Esp Oftalmol. 2018 Dec 01;: Authors: Díaz Llopis M PMID: 30514638 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30514638?dopt=Abstract

Source: Archivos de la Sociedad Espanola de Oftalmologia - December 7, 2018 Category: Opthalmology Tags: Arch Soc Esp Oftalmol Source Type: research

More News: Children | Opthalmology | Study